antibiotics
| 3 min read
New biomarkers can predict risk of patients dying from bacteremia
| 3 min read
Phase 1/2 trial will assess safety and efficacy of RECCE 327 against broad range of infectious diseases on chronic burn wounds
| 4 min read
The AMR Action Fund seeks to support antibiotic candidates in massive industry-philanthropic alliance
| 3 min read
Hoth Therapeutics collaborates with USAMRDC to treat multi-drug resistant bacterial lung infections
